查看文章

Objective

To improve endometrial quality and implantation rates after the administration of platelet-rich plasma in patients with refractory endometrium.

Methods

19 patients undergoing in vitro fertilization, aged between 33 and 45 years with a history of refractory endometrium, to whom platelet rich plasma was given by infusion with a catheter into the uterine cavity on the tenth day of the hormone replacement therapy, and then 72 hours after the first administration.

Results

Endometrial thicknesses> 7mm was reported with the first use; and in all cases, endometrial thicknesses> 9mm were evident after the second administration. The entire study group qualified for Embryo Transfer at the blastocyst stage. We had 73.7% of positive pregnancy tests, of which 26.3% yielded live births; 26.3% ongoing pregnancies; 10.5% biochemical pregnancies; 5.3% anembryonic pregnancies and 5.3% had fetal death (16 weeks …